KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Assets Average (2016 - 2025)

Historic Assets Average for TherapeuticsMD (TXMD) over the last 13 years, with Q3 2025 value amounting to $38.6 million.

  • TherapeuticsMD's Assets Average fell 314.14% to $38.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.6 million, marking a year-over-year decrease of 314.14%. This contributed to the annual value of $41.1 million for FY2024, which is 3860.14% down from last year.
  • TherapeuticsMD's Assets Average amounted to $38.6 million in Q3 2025, which was down 314.14% from $38.4 million recorded in Q2 2025.
  • TherapeuticsMD's 5-year Assets Average high stood at $225.0 million for Q2 2021, and its period low was $38.4 million during Q2 2025.
  • Its 5-year average for Assets Average is $99.3 million, with a median of $56.6 million in 2023.
  • As far as peak fluctuations go, TherapeuticsMD's Assets Average soared by 562.81% in 2021, and later plummeted by 6280.66% in 2023.
  • TherapeuticsMD's Assets Average (Quarter) stood at $189.5 million in 2021, then plummeted by 40.82% to $112.2 million in 2022, then crashed by 58.19% to $46.9 million in 2023, then decreased by 16.45% to $39.2 million in 2024, then fell by 1.53% to $38.6 million in 2025.
  • Its Assets Average was $38.6 million in Q3 2025, compared to $38.4 million in Q2 2025 and $38.5 million in Q1 2025.